Clinical Edge Journal Scan

Clinical Edge Journal Scan

TNBC: Neoadjuvant and adjuvant pembrolizumab prolongs EFS in KEYNOTE-522

Publish date: March 21, 2022

Read More

Clinical Edge Journal Scan

Clinical Edge Journal Scan Commentary: Breast Cancer March 2022

Author:: Erin Roesch, MD

Publish date: February 25, 2022

Read More

Clinical Edge Journal Scan

HR-positive BC: Sulindac relieves musculoskeletal symptoms in patients receiving aromatase inhibitors

Publish date: February 22, 2022

Read More

Clinical Edge Journal Scan

HER2-negative BC: Better pathological response with nab-paclitaxel vs. docetaxel in real world

Publish date: February 22, 2022

Read More

Clinical Edge Journal Scan

HER2-low expression is dynamic in breast cancer

Publish date: February 22, 2022

Read More

Clinical Edge Journal Scan

Early breast cancer: Adding capecitabine prolongs survival in 15-year FinXX trial

Publish date: February 22, 2022

Read More

Clinical Edge Journal Scan

Breast cancer: Fosnetupitant safe in patients receiving AC/EC chemotherapy

Publish date: February 22, 2022

Read More

Clinical Edge Journal Scan

ER+ BC: Reduced recurrence with aromatase inhibitors vs. tamoxifen in premenopausal women

Publish date: February 22, 2022

Read More

Clinical Edge Journal Scan

Breast cancer: PTV of 9 susceptibility genes could guide gene panel testing and risk prediction

Publish date: February 22, 2022

Read More

Clinical Edge Journal Scan

Adding capecitabine to adjuvant chemotherapy improves RFS in non-BRCA1-like early TNBC

Publish date: February 22, 2022

Read More

Clinical Edge Journal Scan

TNBC: Adding carboplatin to neoadjuvant chemotherapy provides long-term EFS benefit

Publish date: February 22, 2022

Read More

Pages